---
schema_version: "secwatch.filing_event.v1"
accession: "0001919246-26-000058"
form_type: "8-K"
ticker: "PTHS"
cik: "0001919246"
company_name: "Pelthos Therapeutics Inc."
filed_at: "2026-04-10T23:59:59+00:00"
generated_at: "2026-05-15T06:43:08.135539+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pelthos Therapeutics appoints John M. Gay as CFO, replaces Francis Knuettel II

## Summary
- John M. Gay appointed CFO effective April 10, 2026; also named treasurer and secretary.
- Gay previously served as SVP, Finance & Accounting since July 2025; prior CFO at LNHC and Novan.
- Francis Knuettel II terminated as CFO effective April 10, 2026; no disagreement cited.
- Gay's employment agreement: $425,000 base salary, 40% target annual bonus.
- Press release issued April 10, 2026; CEO Scott Plesha cites strong commercial momentum.

## SEC filing metadata
- accession: 0001919246-26-000058
- form_type: 8-K
- ticker: PTHS
- cik: 0001919246
- company_name: Pelthos Therapeutics Inc.
- filed_at: 2026-04-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1919246/000191924626000058/0001919246-26-000058-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1919246/000191924626000058/pths-20260410.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001919246-26-000058
- JSON: https://secwatch.observer/filing/0001919246-26-000058.json
- Plain text: https://secwatch.observer/filing/0001919246-26-000058.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.